MktsMarkets

Inhibrx Biosciences, Inc.
NASDAQ: INBXKey statistics
INBX News
Stories mentioning INBX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 1,300 | 0.00 | 100.00 | 0.00 | 100.00 | |
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | |||||||
| Operating Expenses | ||||||||
| Research & Development | 25,217 | 25,349 | 28,535 | 22,267 | 36,877 | 33,367 | 38,893 | 67,632 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 30,927 | 30,923 | 33,812 | 28,689 | 42,901 | 50,028 | 46,797 | 160,998 |
| Operating Income (Loss) | (30,927) | (30,923) | (33,812) | (27,389) | (42,901) | (49,928) | (46,797) | (160,898) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (12.00) | (39.00) | (46.00) | (246.00) | (50.00) | 60.00 | 41.00 | 33.00 |
| Pretax Income | (33,441) | (32,834) | (35,256) | (28,652) | (43,311) | (47,865) | (43,864) | 1,858,013 |
| Tax Provision | 0.00 | 0.00 | 0.00 | 2.00 | 0.00 | 0.00 | 0.00 | 2.00 |
| Net Income (Loss) | (33,441) | (32,834) | (35,256) | (28,654) | (43,311) | (47,865) | (43,864) | 1,858,011 |
| Earnings Per Share (Basic) | (2.15) | (2.12) | (2.28) | (1.85) | (2.80) | (3.23) | (2.84) | 127.10 |
| Earnings Per Share (Diluted) | (2.15) | (2.12) | (2.28) | (1.85) | (2.80) | (3.19) | (2.84) | 125.48 |
| Weighted Average Shares Outstanding (Basic) | 15,585 | 15,487 | 15,478 | 15,468 | 15,468 | 14,802 | 15,468 | 14,619 |
| Weighted Average Shares Outstanding (Diluted) | 15,585 | 15,487 | 15,478 | 15,468 | 15,468 | 14,984 | 15,468 | 14,807 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About INBX
Inhibrx Biosciences, Inc. (NASDAQ: INBX) is a stock listed on the Nasdaq Stock Market under the ticker symbol INBX. It last traded at $90.45 (Nov 10, 2026, 12:11 PM ET), down 1.4% on the day. That gives Inhibrx Biosciences a market capitalisation of $1.4B.
Over the past 52 weeks INBX has traded between $57.30 and $155.29.
For the quarter ended Mar 31, 2026 it reported a net loss of $33.4M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | — | -$33.4M | — |
| Dec 31, 2025 | $0 | -$32.8M | — |
| Sep 30, 2025 | $0 | -$35.3M | — |
| Jun 30, 2025 | $1.3M | -$28.7M | -2204.2% |
From Inhibrx Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…